Home » Newsletters » BioWorld MedTech

BioWorld MedTech

March 7, 2012

View Archived Issues

European Congress of Radiology: Tomosynthesis systems ready to follow on Hologic success

VIENNA No matter how you slice it, Hologic (Bedford, Massachusetts) has created a market for tomosynthesis. Read More

Washington roundup: FDA wants routine audits of Synthes USA after inspection

K2M adds to spine portfolio with FDA clearance of Santorini

NewCo on the Block: Ivantis enrolls first patient in Hydrus Microstent study

Financings roundup: NLT Spine increases funding to a total of $14.5 million

Patent watch: Vermillion gets allowance for platelet biomarkers

Agreements/contracts: Abbott, Merck make FISH diagnostic test

Deals roundup: Excelitas Technologies completes acquisition of Carsan Engineering

Court report: Precision files patent suit against Cellectis

HIT roundup: Fujifilm wins EHR certification for Synapse RIS version 6.1

People in the News

Product Briefs

MDD's Oncology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026